Search

Search Constraints

You searched for: Author/Creator Anolik, Jennifer

Search Results

1. 1702 Patients enrolled in the accelerating medicines partnership (AMP) RA/SLE network with isolated renal disease report minimal quality of life impairment on PROMIS-29 compared to patients with extrarenal symptoms. (14th December 2022)

4. B cells inhibit bone formation in rheumatoid arthritis by suppressing osteoblast differentiation. Issue 1 (December 2018)

6. Disruptive innovation in rheumatology: new networks of global public–private partnerships are needed to take advantage of scientific progress. Issue 5 (5th March 2020)

7. High incidence of proliferative and membranous nephritis in SLE patients with low proteinuria in the Accelerating Medicines Partnership. (25th February 2022)